PORTFOLIO

PORTFOLIO COMPANIES

Quantum Biosystems Inc.

  • President and Chief Executive Officer:
    Toshihiko Honkura

URL:http://www.quantumbiosystems.com/

COMPANY PROFILE

Development and commercialization of a single molecule DNA sequencer based on quantum mechanics.

Quantum Biosystems is pioneering the development of innovative sequencers based on quantum mechanics. Its proprietary Quantum Sequencing[TM] technology achieves single molecule electrical DNA sequencing by integrating cutting edge silicon technology and sophisticated electric detection system to the life sciences. This platform has disrupted DNA sequencing, as it allows a label-free, low-cost, high-throughput, and real-time analysis with no need for complex sample preparation, detection, or analysis.

COMPANY STORY

Origin

Quantum Biosystems was incorporated in January 2013, and is developing
innovative DNA sequencers based on the research results of Osaka University professors,
Tomoya Kawai and Masatomi Taniguchi.

Strength

Using Quantum Biosystems’ technology, it is possible to carry out DNA analysis
easily, with a higher accuracy rate at a remarkably lower cost when compared to conventional technologies. Furthermore, the technology overcomes the limitations of existing technologies in that it can capture DNA modification information.

UTEC’s value add

UTEC offers financial support as the lead investor in the Series A and D rounds. UTEC possesses an external director seat, and proactively supports the management team by providing valuable insights and advice when making important business decisions.
  • Proprietary sequencer and sensors on chip.

RELATED NEWS